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Abstract.  FG human pancreatic carcinoma cells ad- 
here to vitronectin using integrin o~vB5 yet are unable 
to migrate on this ligand whereas they readily migrate 
on collagen in an ot2/31-dependent  manner.  We report 
here that epidermal growth factor receptor (EGFR) ac- 
tivation leads to de novo av/35-dependent FG cell 
migration on vitronectin.  The EGFR specific tyrosine 
kinase inhibitor tyrphostin 25 selectively prevents 
EGFR autophosphorylation thereby preventing the 
EGF-induced FG cell migration  response on vitronec- 
tin without affecting constitutive migration on colla- 
gen.  Protein kinase C  (PKC) activation also leads to 
otv/55-directed  motility on vitronectin;  however, this 
is not blocked by tyrosine kinase inhibitors.  In this 
case, PKC activation appears to be associated with 
and downstream of EGFR signaling  since calphostin 
C, an inhibitor of PKC, blocks FG cell migration on 
vitronectin induced by either PKC or EGE  These 
findings represent the first report implicating a  recep- 
tor tyrosine kinase in a  specific integrin mediated cell 
motility event independent of adhesion. 
C 
ELL migration  plays a critical role in a variety of bio- 
logical processes including embryonic development, 
angiogenesis,  wound repair, and tumor cell metasta- 
sis.  Though the detailed mechanisms  of cell migration  are 
poorly understood, it is clear that adhesion events are crucial 
to this process. The adhesive interactions  between cells and 
the extracellular  matrix are mediated by integrins,  a family 
of cell surface receptors that bind to extracellular  matrix 
proteins  including  vitronectin,  collagen,  and  fibronectin 
(Hynes, 1992). While many cells express integrin receptors 
and are capable of adhesion  their capacity to promote cell 
motility is likely to be regulated  independently  by growth 
factors or cytokines. In fact,  cytokines such as epidermal 
growth  factor  (EGF)  and  insulin-like  growth  factor  one 
(IGF-1)'  induce  cell  motility  of a  wide  variety  of cells 
(Stracke et al.,  1989; Stoker and Gherardi,  1990; Chen et 
al.,  1993;  Matthay  et  al.,  1993).  However,  the  mecha- 
nism regulating cytokine-induced cell motility has not been 
clearly defined. 
FG human carcinoma cells provide a useful model for as- 
sessing  the role of physiological  factors that  regulate cell 
migration.  Specifically, FG cells attach to vitronectin  using 
integrin  t~v~5 yet are  unable  to  migrate  on  this  ligand 
whereas they are competent to migrate on collagen  in an 
ot2~l-dependent  manner  (Leavesley  et al.,  1992).  These 
findings imply that FG cell motility on collagen is regulated 
Address all correspondence to D. A. Cheresh, The Scripps Research Insti- 
tute, Dept. of Immunology, 10666 N. Torrey Pines Rd., La Jolla, CA 92037. 
Tel.:  (619) 554-8281.  Fax:  (619) 554-6705. 
1. Abbreviations used in this paper: FBM, fibroblast basal medium; IGF-1, 
insulin-like growth factor one; PKC,  protein kinase C. 
by intrinsic  intracellular  events  whereas  ore/~5-dependent 
migration  on vitronectin  requires an exogenous stimulus.  In 
this report, we provide direct evidence that the EGF receptor 
(EGFR) stimulates  a protein kinase C-dependent signaling 
pathway leading to the induction of c~v/~5-dependent FG cell 
migration  on a vitronectin  substrate.  These findings provide 
the first  link between the activation  of a  tyrosine kinase 
receptor, protein kinase C, and a specific integrin-mediated 
motility event. Moreover, evidence is presented that this sig- 
naling pathway leads to otv/~5-directed motility but not adhe- 
sion to vitronectin. 
Materials and Methods 
Cells and Cell Culture 
FG human pancreatic carcinoma cells were provided by Dr. Shama Kajiji 
and Vito Quaranta (The Scripps Research Institute, La Jolla, CA). FG-B 
is a subline stably transfected with a full-length eDNA encoding human/~3 
gene and, thus, expresses functional c~v/33 (Leavesley et al., 1992). All cells 
were  grown  in  RPMI  1640  (GIBCO  BRL,  Gaithersburg,  MD)  sup- 
plemented with  10% FBS and 50 izg/ml geatamycin and were free from 
mycoplasma during these studies. Before testing all cells were starved for 
24 h by replacing serum containing culture media with FBS-free RPMI. 
Monoclonal Antibodies and Reagents 
Integrin-spexific mAbs P3G2 (anti-c~v~/5; Wayner et al.,  1991),  6F1  (anti- 
~2/~1; Coller et al.,  1990), LM609 (anti-otv~3; Cheresh and Spiro, 1987), 
P4CI0 (anti-~l; Carter et al.,  1990), and AP3 (anti-/~3; Dr. P.  Newman, 
Blood  Center  of  Southwestern  Wisconsin,  Milwaukee,  WI)  661  (anti- 
vitronectin,  Nip  et  al.,  1992)  were  purified  from  ascites  on  protein 
A-Sepharos¢. MAbs to the epidermal growth factor and insulin-like growth 
factor receptors were obtained from Oncogene Science (Uniondale, NY) 
and PY20 Coiotinylated  anti-phosphotyrosine) was from ICN Biomedicals, 
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din/biotin complex was from Amersham Corp.  (Arlington Heights, IL). 
Tyrphostin 25  ([3,4,5-trihydroxyphenyl]-methylene propanedinitfile) was 
purchased from Calbiochem (San Diego, CA). Tyrphostin 63 ([4-hydroxy- 
benzyl] malonitxile) an analogue that does not inhibit EGFR kinase activity 
was obtained from LC Laboratories (Woburn, MA). Phorbol,  12-myris- 
tate,  13-acetate (PMA), genistein, and calphostin C  were acquired from 
Calbiochem. Human recombinant EGF and IGF-1 were obtained from Gen- 
zyme (Cambridge, MA). 
Adhesive Ligands 
Vitronectin was prepared as described by Yatohgo et al. (1988).  Collagen 
type 1 was obtained from Upstate Biotechnology Inc. (Lake Placid, NY). 
Cell Migration Assay 
Cell migration assays were performed using modified Boyden chambers 
containing polycarbonate membranes (tissue culture treated, 6.5-ram di- 
ameter,  10-#m thickness, 8-#m pores, Transwell®;  Costar, Cambridge, 
MA). The under surface of the membrane was coated with vitronectin or 
collagen (10 #g/ml in PBS, pH 7.4, unless otherwise noted) for 2 h at 37°C. 
Excess ligand was removed and the lower chamber filled with 0.5 ml of 
fibroblast basal medium (FBM) t containing 0.5% BSA (FBM-BSA; Clo- 
netics, San Diego, CA). Cells were harvested with trypsirdEDTA (GIBCO 
BRL) and the trypsin inactivated with soybean trypsin inhibitor (Sigma 
Chem. Co., St. Louis, MO). Cells were washed with FBM-BSA then added 
to the upper chamber (100,000  cells/0.1 ml FBM-BSA) and allowed to mi- 
grate in the presence or absence of the appropriate cytokine or PMA for 
various times at 37°C in 6% CO2. To evaluate the effects of kinase inhibi- 
tors on migration, cells were pretreated with tyrphostin 25  (50 #M  for 
12-16 h, genistein (50 #M for 1 h) or calphostin C (40 nM for 30 rain) be- 
fore being treated with cytokine or PMA for 1 h and then washed and al- 
lowed to migrate as described above. The upper surface of the membrane 
was then wiped with a cotton-tip applicator to remove nonmigratory cells 
and the migrant cells on the under surface fixed and stained for 20 rain with 
1% crystal violet in 0.1 M borate, pH 9.0, and 2% ethanol. The number of 
stained cells per 40x  field were counted with an inverted microscope or 
the dye was eluted with 10% acetic acid and its absorbency determined at 
600 run. Random migration was determined by coating both the lower and 
upper membrane with the appropriate adhesive protein. In a typical experi- 
ment, only a few cells (i.e., 1-5) randomly migrate to the lower membrane. 
Nonspecific or background migration was evaluated on BSA-coated mem- 
branes and subtracted from all data points. In all cases, cell migration on 
BSA was less than 1% of the values obtained with adhesive proteins. Each 
determination represents the average of  three individual wells and error bars 
represent the standard error of the mean (SEM). 
Adhesion Assay 
Cell adhesion was performed according to Leavesley et al. (1992) with mi- 
nor modifications. Briefly,  48-well cluster plates (polystyrene, non-tissue 
culture  treated;  Costar,  Cambridge,  MA)  were  coated  with  10  #g/ml 
vitronectin or collagen 1 in PBS, pH 7.4. Proteins were allowed to bind for 
2 h at 37°C before the wells were rinsed and blocked for 2 h with 2% heat- 
denatured BSA (RIA grade; Sigma) in PBS, pH 7.4.  Cells were harvested 
as for the migration assay and added to the wells at a concentration of 
100,000 cells/0.1 ml FBM-BSA. Nonadherent cells were removed with gen- 
tle washing and cell attachment determined with a colorimetric cell liter as- 
say (Cell Titer 96~';  Promnga Corp., Madison, WI). Each data point was 
calculated from triplicate wells and was expressed as the mean  +  SE. 
Nonspocific cell adhesion as measured on BSA-coated wells has been sub- 
tracted. 
Flow Cytometric Analysis 
Cells pretreated in the presence or absence of EGF (100 ng/ml) for 24 h 
were harvested as for the migration assay,  rinsed twice in ice-cold FACS 
buffer (PBS with 2% FBS and 0.1% sodium azide, pH 7.4) then incubated 
with primary antibodies (10 #g/ml) on ice for 1 h. Cells were washed twice 
with  excess FACS  buffer and  then  incubated with  secondary antibody 
(phycoerytherin-conjugated  goat  anti-mouse  immunoglobulin  [diluted 
1/I00];  Fischer, Pittsburgh, PA) for 45 rain on ice. Cells were analyzed with 
a Becton-Dickinson FACScan flow cytometer. Cell analysis was gated on 
forward and size scatter intensities. The results were presented as single pa- 
rameter histograms. 
Immunoprecipitation and Antiphosphotyrosine 
Blotting of  EGF and IGF-I Receptors 
FG cells were grown to 80%  confluency in T75  flasks (,'o10-15  x  106 
cells/flask with RPMI containing 10%  FBS. The culture media was re- 
moved and the cells incubated in sernm-frev RPMI for 12-16 h in the pres- 
ence or absence of 50 #M tyrphostin. EGF (100 ng/ml) or IGF-I (20 ng/ml) 
was added directly to the flask containing the labeled cells for 1 h at 37°C 
then rinsed twice with ice-cold Hanks balanced salt solution (pH 7.4) con- 
taining 2 mM sodium vanadate and isolated with a rubber policeman. Cells 
were lysed with RIPA buffer 100 mM Tris, 0.15 M NaCI,  1% dcoxycholic 
acid,  1% Triton X-100, 0.1% SDS,  1% aprotinin, 2 mM PMSE  10/zg/ml 
leupeptin, and 5 mM EDTA supplemented with 2 mM sodium vanadate for 
1 h at 4°C. The lysate was clarified by centrifugation at 14,000  rpms for 
20 min and the amount of total protein determined using the BCA protein 
assay reagent (Pierce Chem. Co., Rockford, IL). Protein concentration was 
normalized to 500 #g/ml with RIPA buffer then preabsorbed with an equal 
volume of pansorbin (Calbiochem) for 2-4 h at 4°C. The paasorbin was re- 
moved by centrifugation at  14,000  rpms for  l0  min and the receptors 
precipitated with anti-EGF and anti-IGF-1 receptor antibodies bound to 
protein G (10 #g antibody/10 #l stock bead suspension; Pierce) for 16 h at 
4°C. The beads were then washed three times with each of the following 
buffers: RIPA, PBS with 0.5% tween 20 and 1 mg/ml ovalbumin, and PBS 
0.5 % Tween 20. Immunoprecipitates were resnspended in SDS electropho- 
resis sample buffer with 5% 2-mercaptoethanol and then heated to 100°C 
for 5 min. Receptors were resolved by sodium dodecyl sulfate-polyacryl- 
amide gel electrophoresis on 6% gels under reducing conditions. Western 
analysis of immunoprecipitates was  performed using  biotinylated anti- 
phosphotyrosine monocional antibody (PY20) and horseradish peroxidase- 
conjugated strepavidin/biotin complex and the ECL system (Bronstein et 
al.,  1992). 
Results 
EGF Specifically Promotes FG Cell Migration 
on Vitronectin 
FG human carcinoma cells attach to vitronectin but are un- 
able to migrate on this ligand whereas they readily attach to 
and migrate on collagen  (Leavesley et al.,  1992).  These 
findings suggest that migration on vitronectin requires an ad- 
ditional  stimulus.  Because  EGF  and  other cytokines are 
known to promote migration of a wide variety of cell types, 
we  investigated the possibility that FG cell migration on 
vitronectin could be induced with EGF. As shown in Fig. 1, 
EGF promotes FG cell migration on vitronectin in a dose- 
dependent manner. Migration was maximal at 100 ng/ml and 
could be inhibited with a monoclonal antibody to the EGF 
receptor.  Similar  results  were  observed when cells  were 
pretreated with EGF (100 ng/ml) for 1 h, rinsed and then al- 
lowed to migrate for 24 h (data not shown). As previously 
reported (Leavesley et al,,  1992), FG Cell migration on col- 
lagen takes place in the absence of EGF and as we show here 
is not stimulated by this cytokine (Figs.  1 and 2) indicating 
that FG cell migration on these matrix proteins are regulated 
by distinct intracellular pathways. Furthermore, cell migra- 
tion on vitronectin and collagen showed the same dose re- 
sponse where the half maximal ligand coating concentration 
is 2-3 #g/ml (Fig. 2). It is important to note that in the ab- 
sence of EGF FG cells are incapable of cell migration on 
vitronectin  even  at  the  superoptimal  dose  of 20  #g/ml 
(Fig. 2). 
lntegrin ~v[35 Mediates EGF-induced FG Cell 
Migration on Vitronectin 
FG cells utilize integrin orcfl5 as their primary vitronectin 
receptor since they fail to express oc¢/33 (Cheresh et al., 
1989; Leavesley et al.,  1992). To investigate whether avfl5 
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Figure 2. Effect of  EGF on FG 
cell migration on various con- 
centrations  of vitronectin  or 
collagen.  Cell  migration was 
evaluated  using  a  modified 
Boyden  chamber  with  a  po- 
rous  membrane  coated  with 
various concentrations of vi- 
tronectin (A) or collagen  (B). 
Cells were allowed to traverse 
the membrane for 24 h in the 
presence  (triangles)  or  ab- 
sence  (circles) of EGF  (100 
ng/ml). Cells were then stained 
and  counted  or  enumerated 
from dye uptake as described 
in  Materials  and  Methods. 
Each  point  represents  the 
mean +  SE of three replicate 
wells. 
Figure 1. Effect of EGF on FG cell migration on vitronectin or col- 
lagen. Cell migration on vitronectin (,4) or collagen (B) was deter- 
mined using a modified Boyden chamber with a 8-#m porous mem- 
brane coated with the appropriate extracellular  matrix protein (10 
/~g/ml). Cells  were allowed to traverse  the membrane for 24 h in 
the presence of various concentrations of EGF or EGF (100 ng/ml) 
plus anti-EGFR antibodies  (10 #g/ml). The cells were then stained 
and  counted  or  enumerated  from  dye  uptake  as  described  in 
Materials  and Methods.  Each bar represents  the mean  +  SE of 
three replicate  wells. 
was responsible for mediating EGF-induced FG cell migra-  ~" 
o 
tion on vitronectin, cell migration assays were performed in  o 
the presence of specific anti-integrin monoclonal antibodies.  "~ 
As shown in Fig.  3, mAb P3G2 to a  functional epitope on 
integrin av/~5 inhibited EGF-induced FG cell migration on 
vitronectin but had no effect on collagen-dependent migra-  .-~ 
tion. Similarly, mAb 661 to vitronectin specifically inhibited  ._~ 
migration on this ligand. In contrast, mAb P4C10 to the/31  = 
integrin subunit inhibited migration on collagen but failed to 
affect EGF-induced migration on vitronectin.  As expected,  o 
mAb LM609 directed to czv/33, not expressed by these ceils, 
had no effect on migration on either ligand. These data dem- 
onstrate that EGF-induced migration on vitronectin is medi- 
ated by the integrin otvB5. 
EGF Does Not Alter Integrin Expression on FG Cells 
To  determine  whether  EGF-induced  cell  migration  on 
vitronectin  was  the  result  of a  quantitative  change  in  the 
number of surface receptors, cells were treated in the pres- 
ence or absence of EGF for 24 h and examined for cell sur- 
face integrin otv~5 and ctvB3 or the EGFR. As shown in Fig. 
4, exposure of FG cells to EGF dramatically decreases the 
number of EGF receptors on the cell surface as previously 
reported  for cells  exposed  to  EGF  (Das  and  Fox,  1978). 
However, this treatment did not influence the expression of 
integrins  otv/35 or otv/33 (Fig.  4).  Thus,  EGF-induced cell 
migration on vitronectin is not the result of increased surface 
expression of etv#5 or de novo expression of the vitronectin 
receptor ctv/33. 
EGF Has No Quantitative Effect on FG Cell Adhesion 
to Vitronectin but Promotes Cell Spreading 
We  investigated  whether  EGF-induced  cell  motility  on 
vitronectin was due to activation of avB5 leading to a quan- 
titative change in FG cell adhesion to vitronectin. Cells in- 
cubated in the presence or absence of EGF were allowed to 
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Figure 3. Role of avfl5 in EGF-induced cell migration on vitmnec- 
tin.  FG cell  migration on vitroneetin  (hatched bar)  or collagen 
(shaded bar) was performed in the presence of monoclonal anti- 
bodies (50 t~g/ml) to functional  epitopes on vitronectin (VN; 661) 
or integrins  czvfl5 (P3G2), c~vB3 (LM609), and fll (P4C10).  Cell 
migration was performed as described in Materials  and Methods. 
Each bar represents  the mean percentage migration relative  to an 
EGF-stimulated  control in the absence of antibody +  SE of three 
replicate  wells. 
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Figure 4. Effect of EGF on EGF receptor and integrin expression. 
Cells pretreated with EGF (bottom) or control buffer (top) for 24 h 
were stained with either anti-EGFR or anti-integrin antibodies to 
o~vB5 (P3G2), ot231 (6F1), and/33 (AP3). The cells were rinsed, 
stained with phycoerytherin-conjugated secondary antibody, and 
analyzed with a FACScan flow cytometer. The bar represents back- 
ground fluorescence of cells treated with an irrelevant antibody. 
The results are presented as single parameter histograms. 
attach to wells coated with vitronectin or collagen for vari- 
ous times. As shown in Fig. 5, A and B, EGF did not alter 
the rate or number of FG cells attached to vitronectin or col- 
lagen compared to those cells not treated with EGE Thus, 
EGF-induced FG cell migration on vitronectin was not the 
result  of a  general  increase  in  cell  adhesiveness  to  this 
ligand. 
Cell migration not only depends on adhesion but also on 
the ability of cells to change shape in response to their sub- 
strate. Because cell spreading is a prominent feature of mo- 
tile cells, we investigated the possibility that EGF induces 
FG cell spreading on vitronectin. Cells were incubated in the 
presence or absence of EGF and then allowed to attach and 
spread on coverslips coated with vitronectin or collagen. As 
shown in Fig. 5 C, FG cells not treated with EGF attach yet 
fail to spread on vitronectin whereas they readily attach and 
spread  on  collagen.  However, pretrealment of cells  with 
EGF promoted measurable spreading on vitronectin (Fig. 
5 C).  In  this  case,  a  significant  number  of these  cells 
(40-50%) spread after 2-4 h. Thus, FG cell spreading and 
migration on vitronectin requires activation with a cytokine 
such as EGF while collagen-dependent spreading and migra- 
tion does not. These results suggest that the ability of EGF 
to promote FG cell migration on vitronectin may be linked 
to its capacity to induce spreading on this ligand. 
EGF-induced FG Cell Migration on Vitronectin 
Requires Autophosphorylation of the EGFR 
Autophosphorylation of tyrosine kinase receptors by their 
ligands represent an initial signaling event in a pathway lead- 
ing to intracellular kinase activity resulting in cellular re- 
sponses  including proliferation and motility (Ullrich and 
Schlessinger, 1990). To determine if phosphorylation of the 
EGFR was necessary for EGF-induced FG cell migration on 
vitronectin, we utilized tyrphostin 25, a specific inhibitor of 
the EGFR tyrosine kinase. FG cells pretreated with or with- 
out 50  /zM  tyrphostin 25  were  stimulated  to migrate on 
vitronectin with EGE  As  shown in Fig.  6,  tyrphostin 25 
significantly inhibited EGF-induced migration on vitronec- 
tin while having no effect on collagen migration. This effect 
was dose-dependent reaching maximum inhibition at 50-100 
#M (data not shown). Moreover, cells washed free of the in- 
hibitor  and  cultured  for  24  h  showed  restored  EGF- 
dependent migration on vitronectin demonstrating that the 
effects of tryphostin 25 were fully reversible and not toxic 
(data not shown). In addition, an analogue of  tyrphostin (tyr- 
phostin 63) that does not block autophosphorylation of the 
EGFR had no effect on EGF-induced migration on vitronec- 
tin at similar concentrations (data not shown). 
In a parallel experiment, the effect of tyrphostin 25 on cell 
attachment was examined. In this case, the drug had no effect 
on cell attachment to vitronectin or collagen (Fig. 6).  In- 
terestingly, cell spreading on vitronectin but not on collagen 
was blocked by tyrphostin 25 indicating that the ability of 
EGF to promote FG cell migration may be linked to activa- 
tion of the EGFR tyrosine kinase (data not shown). In addi- 
tion, tyrphostin 25 did not inhibit cell spreading and migra- 
tion on vitronectin of FG cells transfected with the t3 gene 
as these events are constitutive and depend on de novo ex- 
pression  of integrin  c~vB3 (Fig.  7)  as  shown  previously 
(Leavesley et al.,  1992). Taken together, these results indi- 
cate that tyrphostin 25 specifically inhibits c~v155-dependent 
EGF-induced cell spreading and migration on vitronectin 
without affecting cell attachment to this ligand. 
EGF and other cytokines activate specific as well as com- 
mon intracellular signaling pathways leading to a number of 
important biological processes. In fact, both EGF and IGF-1 
activate protein kinase C (PKC) which is thought to mediate 
signaling events involved in various cellular processes (Co- 
chet et al., 1984; Lin et al., 1986; Czech, 1989). Therefore, 
to establish the specificity of the EGF-signaling pathway we 
examined the ability of  tyrphostin 25 to inhibit cell migration 
on vitronectin induced by activation of IGF-1R another tyro- 
sine kinase receptor or PMA, a potent activator of PKC. FG 
cells treated with these agonists for 1 h were washed, rinsed, 
and allowed to migrate for various times. As shown in Fig. 
8 A, EGF, IGF-1, and PMA all stimulate FG cell migration 
on vitronectin. Increasing the concentration or length of ex- 
posure to the agonists did not increase their migration (data 
not shown).  It is important to note that IGF-1  and PMA- 
induced cell motility on vitronectin is also mediated by ,v/35 
since anti-olv/35 antibodies specifically blocked migration on 
this ligand (data not shown). As shown in Fig. 8 B, tyrphostin 
25 only blocked EGF-dependent motility since it failed to in- 
hibit motility induced by IGF-1 or PMA. These results dem- 
onstrate that the effects of tyrphostin 25 are due to its ability 
to specifically block migration induced by the EGFR. How- 
ever, direct activation of PKC by phorbol ester can appar- 
ently bypass the tyrphostin 25 inhibitable signaling event ini- 
tiated by the EGFR. In support of this contention, the PKC 
inhibitor calphostin C blocks EGF, IGF-1, as well as PMA- 
induced <xv/35-directed FG cell migration on vitronectin (Ta- 
ble I), yet has no effect on cell migration on collagen (data 
not shown). Also, genistein (an inhibitor of EGFR as well 
as IGF-1R tyrosine kinase activity) blocks motility induced 
by either cytokine, yet has no effect on PMA-induced cell 
migration. These results indicate that PKC is associated with 
and downstream from the EGF or IGF-I signaling pathway 
leading to wcfl5-dependent motility (Table I). 
Tyrosine kinase receptor signaling events are typically ini- 
tiated by autophosphorylation of the receptor. As shown in 
Fig. 9 A, EGF and IGF-1 readily stimulate autophosphoryla- 
tion of their respective receptors. However, cells pretreated 
with tyrphostin 25, then stimulated with EGF showed basal 
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Figure 5. Effect of  EGF on FG cell adhesion and spreading on vitronectin and collagen.  (A and B) Cells pretreated  in the presence (triangles) 
or absence (circles) of EGF (100 ng/ml) for 24 h were allowed to adhere to vitroneetin or collagen for various times.  Unattached cells 
were removed by washing and the remaining cells quantified  by measuring the conversion of MTT tetrazolium salt to formzTzn dye (see 
Materials  and Methods).  Cell attachment to BSA-coated wells was subtracted  as background. Each point represents  the mean +  SE of 
three replicates.  (C) Cells pretreated  in the presence or absence of EGF (100 ng/ml for 24 h) were allowed to attach and spread on glass 
coverslips coated with vitronectin or collagen (40 tLg/ml) for 4 h before being photographed at 300 x  magnification as described in Materials 
and Methods. 
levels of  EGFR autophosphorylation. In contrast, tyrphostin 
25 had no effect on IGF-l-induced IGF-1R autophosphoryla- 
tion.  These results demonstrate that tyrphostin 25  specifi- 
cally  inhibits  EGFR  activation  while  having  no  effect on 
IGF-1R tyrosine kinase and this likely accounts for its selec- 
tive effect on EGF-induced FG cell migration on vitronectin 
(Fig. 8). We also examined the ability of  the anti-EGFR anti- 
body to block autophosphorylation of the EGFR. This anti- 
Klemke et al.  Tyrosine Kinase and lntegrin-dependent Cell Migration  863 Figure 6. Effect of  the tyrosine 
.-g  kinase inhibitor tyrphostin 25 
~  on'  FG  cell  migration  and 
g8  adhesion.  Ceils  were  pre- 
=-  treated  with  tyrphostin  25  l=  O 
_~  (50  #M)  for  12-14 h  before 
=  being  stimulated  with  EGF 
(100 ng/ml) for 1 h. The cells 
were rinsed and then either at- 
Migration  Adhesion  lowed  to migrate on vitronec- 
tin (hatched bar) or collagen 
(shaded bar) for 12 h or tested in a 2-h adhesion assay as described 
in Materials and Methods. Each bar represents the mean percent- 
age migration/adhesion relative to an EGF stimulated control in the 
absence of tyrphostin 25  +  SE of triplicate wells. 
body blocks EGF-induced motility on vitronectin (Fig. 1) and 
as shown as in Fig. 9 B, also blocks EGFR autophosphoryla- 
tion. Together these findings demonstrate that (xvB5-directed 
motility of FG cells depends on a signaling pathway medi- 
ated by the activation of receptor tyrosine kinases and pro- 
tein kinase C. 
Discussion 
Evidence presented  in  this  study  demonstrates  that  EGF 
promotes  txv/35-dependcnt  carcinoma  cell  migration  on 
vitronectin and this depends on activation of the EGFR tyro- 
sine kinase and PKC. These findings provide the first link be- 
tween activation of a receptor tyrosine ldnase, PKC, and an 
integrin-dependent motility event. 
Previous studies from our laboratory have shown that FG 
cells  express  integrin  o~v/55 as  their  primary  vitronectin 
receptor yet they are unable to migrate on this ligand even 
though they readily migrate on collagen using integrin ot2/~l 
(Leavesley et at., 1992). Moreover, FG cells transfected with 
a eDNA encoding the B3 subunit express integrin (xvB3 en- 
abling them to constitutively migrate on a vitronectin sub- 
strate.  These findings  suggest that integrin otv/~5 requires 
an  exogenous  stimulus  to  engage the  motility machinery 
whereas integrins (x2/~l and (xv/~3 on these cells do not. 
It is well documented that EGF as well as other cytokines 
induce motility of a variety of cell types, however, little is 
known  about  the  intracellular  factors  that  mediate  these 
events  (Stoker  and  Gherardi,  1991).  Results  from recent 
studies imply that integrins may function cooperatively with 
cytokines and growth factors to integrate and transmit sig- 
nals required for cell attachment and motility (Chen et at., 
_  Figure Z Effect of tyrphostin 
25  on  FG-B  cell  migration. 
,~  FG  cells  stably  transfected 
o~  with  a  cDNA  encoding  /33 
=  (FG-B  cells  express  integrin 
,  ~xv~3, Leavesley et el,, 1992) 
,~  were pretreated for 12-14 h in 
the presence (shaded bar) or 
o  absence (hatched bar) of tyr- 
Vltronectln  Collagen  phostin 25 (50 #M) and then 
allowed to migrate on vitro- 
nectin or collagen for 24 h. Cell migration was enumerated from 
dye uptake as  described  in  Materials  and  Methods.  Each  bar 
represents the mean +  SE of triplicate wells. 
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Figure 8. Effect of tyrphostin 25 on PMA and IGF-1 stimulated FG 
cell migration on vitronectin. (,4) Cells were pretreated with buffer 
(control), EGF (100 ng/ml), PMA (5 ng/ml), or IGF-1 (20 ng/ml) 
for 1 h then washed and allowed to migrate for various times. (B) 
Cells were pretreated in the presence (tilled bar) or absence (stip- 
pled bar) of 50 #M tyrphostin 25 for 12-16 h before being stimu- 
lated with cytokin¢ or PMA as described above. Cells were allowed 
to migrate for 18-24 h. Each bar or point represents the mean  + 
SE of triplicate wells. 
1993;  Matthay et al.,  1993).  Therefore,  we examined the 
ability of various cytokines to promote FG cell migration on 
vitronectin. EGF and IGF-1, two activators of receptor tyro- 
sine  kinases,  were found to  specifically promote FG cell 
migration on vitronectin since they had no effect on FG cell 
migration on collagen. In addition, PKC activation promoted 
FG cell migration on vitronectin. It is of interest to note that 
EGF and IGF-1 are cytokines whose activity can result in 
PKC  activation (Rosen et at.,  1991;  Tramm et al.,  1991; 
Halaban et al.,  1992). Our results demonstrate that PKC is 
downstream from the EGFR stimulation since calphostin C 
blocks EGF, IGF-1, and PMA-induced motility without ef- 
fecting cell adhesion to vitronectin. This contention is also 
supported by the finding that tyrosine kinase inhibitors block 
migration induced by EGF and IGF-1 but not PMA. Thus, 
,v/35-dependent migration of FG cells requires activation of 
a receptor tyrosine kinase and PKC while ot2Bl-dependent 
motility of these cells involves a completely distinct signal- 
ing pathway. 
The specific mechanism responsible for EGF-induced FG 
cell migration on vitronectin remains to be elucidated. How- 
ever, it is clear that this motility event is not the result of a 
The Journal  of Cell Biology, Volume 127, 1994  864 Table L  Effect of Tyrosine Kinase and Protein Kinase C lnhibitors on Agonist-induced Migration 
Inhibitor  No treatment  EGF  IGF-1  PMA 
No inhibitor  16.3  +  4*  1638 +  31  991  -1- 116  1553 +  42 
Calphostin  C~  NT¶  334  +  54  131  +  53  584  +  55 
Tyrphostin 25§  NT  463  +  36  763  +  64  1495 +  25 
GenisteinU  NT  584  +  55  226  +  56  1474 +  49 
* FG cells were either pretreated in the presence  or absence  of inhibitors and then treated with buffer  (no treatment), EGF (I(K)  ng/ml), IGF-I (20 ng/ml)  or PMA 
(5 ng/ml) for 1 h. Cells were washed and then allowed to migrate for 24 h before being stained and counted as described in the Materials and Methods. Values 
represent the mean +  SE of the number of cells migrating per field of three replicate wells. 
¢ Specific inhibitor of protein kinase C. 
§ Specific inhibitor of EGF receptor tyrosine kinase. 
tl General inhibitor of tyrosine kinase. 
¶ NT, not tested. 
general  increase  in  the  number  of cell  surface  vitronectin 
receptors since EGF did not alter expression of ctv/35 or pro- 
mote  de  novo  expression  of t~v/33.  Furthermore,  FG  cell 
adhesion  to  vitronectin  was  not  quantitatively  affected  by 
EGF treatment. Interestingly, EGFR activation did promote 
FG cell spreading on vitroneetin which may facilitate migra- 
tion of these cells. The ability of otv/35 to respond to EGFR 
signaling may be due to direct phosphorylation of the otv or 
135 subunit  (Freed et al.,  1989).  Alternatively,  after EGFR 
activation, other cytoplasmic factors may become associated 
with a,v/35  or influence its ability to interact with the actin 
cytoskeleton  which,  in  turn,  may  promote  spreading  and 
motility of FG cells on vitronectin. 
The EGF receptor possesses intrinsic tyrosine kinase ac- 
tivity that is central to the regulation of a wide range of bio- 
logical  responses  including  cell  proliferation  and  motility 
(Ullrich and Schlessinger,  1990; Chen et al.,  1994). It is now 
clear  that  EGF  binding  leads  to  phosphorylation  of  the 
receptor and to various intracellular  substrates that are im- 
portant  for  transmitting  intracellular  signals  (Ullrich  and 
Schlessinger,  1990). Tyrphostins are a family of potent tyro- 
sine kinase inhibitors that have been used as indicators of the 
involvement of the tyrosine  kinases  in a  variety of cellular 
processes (Yaish et al.,  1988;  Faaland et al.,  1991;  Merkel 
et al.,  1993). In fact, one such compound, tyrphostin 25, has 
been shown to selectively inhibit the EGFR tyrosine kinase 
activity. (Yaish et al.,  1988;  Gazit et al.,  1989;  Lyall et al., 
1989). Moreover, this inhibitor is known to selectively block 
EGFR  kinase  activity  without  affecting  EGF  binding  or 
EGF-induced degradation and down regulation of EGFRs in 
intact cells (Lyall et al.,  1989;  Faaland et al.,  1991).  There- 
fore, we utilized tyrphostin 25 to examine the role of EGFR 
stimulated cell migration on vitronectin. Several lines of evi- 
dence  indicate  that  this  kinase  inhibitor  specifically  im- 
pacted  the  EGFR  signaling  pathway  leading  to  FG  cell 
migration  on  vitronectin.  First,  tyrphostin  25  inhibited 
migration on vitronectin without affecting the intrinsic abil- 
ity of FG cells to migrate on collagen.  Also, transfection of 
FG cells with a eDNA encoding/33  promoted expression of 
txvfl3  enabling  these  cells  to  constitutively  migrate  on 
vitronectin and this was not inhibitable with tyrphostin 25. 
Second,  tyrphostin 25 had no effect on FG cell adhesion to 
vitronectin or collagen indicating the effects were restricted 
to o~vB5-dependent cell motility. Third, two other activators 
of  FG  cell  motility,  namely,  IGF-1  and  PMA,  were  not 
affected by this inhibitor.  Finally,  tyrphostin 25  selectively 
inhibited  ligand-induced  autophosphorylation  of the EGFR 
but not the IGF-1R within FG cells. These results suggest that 
the  EGFR  kinase  is  critical  for the  EGF-induced  FG  cell 
migration  on  vitronectin  via  integrin  c~v/35. The  recent 
finding that EGF-induced receptor autophosphorylation and 
tyrosine kinase activity was required for motility and disper- 
sion of murine  fibroblast ceils  transfected  with  the human 
EGFR  is  consistent  with  this  notion  (Chen  et  al.,  1994). 
Thus,  our results  demonstrate  that cytokine receptor tyro- 
sine kinases play an important role in the regulation of a sig- 
naling pathway leading to the induction of cell motility. The 
specific activation of av/35 and its engagement with the mo- 
tility machinery may impact the biological properties of cells 
expressing this integrin which include most if not all epithe- 
Figure 9.  Effect of tyrphostin 
25 on EGF and IGF-1 induced 
receptor tyrosine phosphory- 
lation. Detergent lysates from 
FG cells were resolved on 6% 
gels, transferred to nitrocellu- 
lose,  and  Western  blotted 
using antiphosphotyrosine an- 
tibodies as described in Mate- 
rials and  Methods.  (A) Anti- 
phosphotyrosine blot of EGF 
and  IGF-1  receptors  isolated 
by immunoprecipitation from 
FG cells treated as in Fig. 8 B. 
(B) Antiphosphotyrosine blot 
of proteins (10 #g/lane) from 
FG cells treated as in Fig.  1. 
Klemke et al. Tyrosine Kinase and lntegrin-dependent Cell Migration  865 lial cells (Pasqualini  et al.,  1993).  Moreover, our findings 
provide the first link between the activation  of a tyrosine ki- 
nase receptor and an integrin mediated motility event. These 
results  support  the  contention  that  cross-talk  between 
cytokines and specific integrins may be important for the in- 
duction of cell motility during embryonic development, an- 
giogenesis, and wound repair. 
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